ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $46,322,000 | +13.3% | 498,627 | -26.9% | 0.92% | +19.4% |
| Q3 2021 | $40,886,000 | -23.9% | 682,116 | -11.2% | 0.77% | -12.2% |
| Q2 2021 | $53,707,000 | +6.5% | 768,018 | +5.7% | 0.88% | -2.1% |
| Q1 2021 | $50,408,000 | +173.3% | 726,447 | +202.6% | 0.90% | +121.5% |
| Q4 2020 | $18,442,000 | -4.4% | 240,033 | -6.9% | 0.40% | -34.0% |
| Q3 2020 | $19,283,000 | -1.2% | 257,829 | -16.9% | 0.61% | -11.6% |
| Q2 2020 | $19,524,000 | +53.8% | 310,143 | +2.6% | 0.69% | +17.5% |
| Q1 2020 | $12,697,000 | -12.6% | 302,313 | -5.5% | 0.59% | +16.6% |
| Q4 2019 | $14,530,000 | +21.5% | 319,900 | +22.5% | 0.50% | +17.4% |
| Q3 2019 | $11,954,000 | -49.7% | 261,171 | -35.5% | 0.43% | -43.1% |
| Q2 2019 | $23,749,000 | +93.1% | 405,058 | +27.9% | 0.76% | +30.6% |
| Q4 2018 | $12,300,000 | +40.2% | 316,684 | +56.3% | 0.58% | +74.9% |
| Q3 2018 | $8,775,000 | +19843.2% | 202,561 | +51.8% | 0.33% | +10933.3% |
| Q2 2018 | $44,000 | -98.9% | 133,424 | +16.1% | 0.00% | -98.8% |
| Q1 2018 | $4,056,000 | +107.4% | 114,890 | +112.7% | 0.25% | +74.5% |
| Q4 2017 | $1,956,000 | – | 54,012 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |